Typhoid Vaccine Wyeth - Biotech, Pharma and Life Science Channel

15:05 EST 6th March 2015 | BioPortfolio

PubMed Articles [1579 Associated PubMed Articles listed on BioPortfolio]

Evaluating potential T-cell epitope peptides for detecting HIV-specific T cell responses in a highly diverse HIV-1 epidemic from Cameroon.

HIV genetic diversity is a major obstacle for vaccine development. To define whether potential T-cell epitope (PTE) peptide usage improves the detection of T cell responses in a highly diverse HIV-1 e...

Update: Influenza Activity - United States, September 28, 2014-February 21, 2015.

Influenza activity in the United States began to increase in mid-November, remained elevated through February 21, 2015, and is expected to continue for several more weeks. To date, influenza A (H3N2) ...

Conformational Dynamics and Antigenicity in the Disordered Malaria Antigen Merozoite Surface Protein 2.

Merozoite surface protein 2 (MSP2) of Plasmodium falciparum is an abundant, intrinsically disordered protein that is GPI-anchored to the surface of the invasive blood stage of the malaria parasite. Re...

Generation of Influenza Virus from Avian Cells Infected by Salmonella Carrying the Viral Genome.

Domestic poultry serve as intermediates for transmission of influenza A virus from the wild aquatic bird reservoir to humans, resulting in influenza outbreaks in poultry and potential epidemics/pandem...

Correction: Determinants of Acceptance and Subsequent Uptake of the HPV Vaccine in a Cohort in Eldoret, Kenya.

[This corrects the article DOI: 10.1371/journal.pone.0109353.].

Emergency Postexposure Vaccination With Vesicular Stomatitis Virus-Vectored Ebola Vaccine After Needlestick.

Safe and effective vaccines and drugs are needed for the prevention and treatment of Ebola virus disease, including following a potentially high-risk exposure such as a needlestick.

Long-Term Efficacy of a Hepatitis E Vaccine.

Background Hepatitis E virus (HEV) is a leading cause of acute hepatitis. The long-term efficacy of a hepatitis E vaccine needs to be determined. Methods In an initial efficacy study, we randomly assi...

Making Hepatitis E a Vaccine-Preventable Disease.

A hepatitis E vaccine could become a powerful new tool in the prevention and control of hepatitis E virus transmission and disease. Most immediately, it can have a role in curbing outbreaks of hepatit...

Relationship between Antibody Susceptibility and Lipopolysaccharide O-Antigen Characteristics of Invasive and Gastrointestinal Nontyphoidal Salmonellae Isolates from Kenya.

Nontyphoidal Salmonellae (NTS) cause a large burden of invasive and gastrointestinal disease among young children in sub-Saharan Africa. No vaccine is currently available. Previous reports indicate th...

Coinjection with TLR2 Agonist Pam3CSK4 Reduces the Pathology of Leishmanization in Mice.

Cutaneous leishmaniasis caused by Leishmania major is an emergent, uncontrolled public health problem and there is no vaccine. A promising prophylactic approach has been immunotherapy with Toll-like r...

News Articles [2763 Associated News Articles listed on BioPortfolio]

Merck and NewLink Ebola vaccine trial begins

Merck and US-based biopharma firm NewLink Genetics’ investigational Ebola vaccine is being used in Phase III trials in West Africa. Vaccine candidate rVSV-EBOV will be tested from tomorrow in Guinea...

State Highlights: MassHealth Savings Key To Balancing State Budget; Calif. Chiropractors Lobby Against Bill Ending Vaccine Exemptions

A selection of health policy stories from Massachusetts, California, Wisconsin, Utah, Georgia, Wyoming, Iowa and Colorado.

Global Specimen Solutions, Inc. Closes Series A Funding

GSS Builds Momentum for Specialty Specimen CRO Services and Infrastructure Cary, NC (PRWEB) March 06, 2015 Global Specimen Solutions, Inc. (http://www.globalspecimensolutions.com), an innovative spec...

Biotech investing easy as ABC: Contractor agrees work for stock deal

ABC Laboratories has agreed to provide privately-owned cancer vaccine firm Immunophotonics with development services in exchange for company stock.

WHO reports launch of Merck/NewLink VSV-EBOV vaccine trial in Guinea

The World Health Organization has reported the launch trials of the VSV-EBOV vaccine for Ebola in Guinea,…

New Technologies, New Vaccines Conference Provides Opportunity to Share New Advancements in Combating Emerging Infectious Diseases, Including Ebola

More than 100 scientists, business leaders and regulatory agency representatives from around the world will convene at the Hotel DuPont in Wilmington, DE from March 22–25, 2015 ...

2015’s biggest health story was broken by a doctor, not a reporter

Measles Makes an Unwelcome Visit to Disneyland Health Alert after Disneyland linked to measles outbreak Mickey, Minnie and measles for nine Disneyland tourists The headlines from January 7th and 8th t...

Opdivo gains new US lung cancer licence

Adds to Bristol-Myers Squibb’s therapeutic vaccine’s melanoma indication

Pfizer's Pneumonia Vaccine Prevenar Okayed for Adults in EU

Pfizer receives European approval for new indication for Prevenar 13 for the prevention of vaccine-type pneumococcal pneumonia in adults

Microbix Announces Annual and Special Meeting Voting Results

TORONTO, ONTARIO -- (Marketwired) -- 03/06/15 -- Microbix Biosystems Inc. (TSX: MBX) ("Microbix" or the "Company"), an innovator of biological products and technologies, announces the results of the...

Events [0 Results]

None

Companies [90 Associated Companies listed on BioPortfolio]

The Vaccine & Gene Therapy Institute of Florida (VGTI Florida)

Targovax

Targovax was started in October 2010 to develop TG01, a vaccine targeting pancreatic cancer. TG01 is based on research from The Radium Hospital and Norsk Hydro in the end of the 9...

Genocea Biosciences

Genocea Biosciences was founded in 2006 to commercialize key breakthroughs in vaccine discovery and development. The Company’s proprietary T cell-directed antigen disc...

The Vaccine & Gene Therapy Institute of Florida

ImmusanT Inc.

ImmusanT is a privately-held biotechnology company focused on restoring tolerance to gluten in celiac disease by harnessing new discoveries in immunology that aim to improve diagn...

Affinivax Inc.

Affinivax is advancing a next generation conjugate vaccine technology platform to enable the development of vaccines that provide the highest level of protection against challengi...

Mucosis B.V.

Mucosis B.V. (Mucosis) is a clinical-stage biotechnology company using a proprietary technology platform to develop next-generation needle-free human vaccines for infectious disea...

Vaxart, Inc.

Vaxart is a privately owned company developing oral recombinant vaccines based on its proprietary delivery platform. The Vaxart platform is suitable to deliver any protein vaccine...

Mucosis

Mucosis B.V. is a clinical-stage biotechnology company developing novel vaccines on its proprietary Mimopath® platform technology. The Mimopath® platform is being studied fo...

Shoo the Flu

The flu, also called influenza, is a contagious disease that spreads by coughing, sneezing and close contact. Flu symptoms include fever/chills, sore throat, muscle aches, fatigue...

Clinical Trials [2140 Associated Clinical Trials listed on BioPortfolio]

Safety and Tolerability Study for the Pneumococcal Conjugate Vaccine V114 Versus Prevnar™ (V114-001 EXT1)(COMPLETED)

This study is being conducted to evaluate the safety, tolerability, and immunogenicity of 15-valent Pneumococcal conjugate vaccine (V114) compared to Prevnar™ in healthy adults and toddl...

Evaluation of Immunogenicity and Safety of Two 2-dose Human Papillomavirus (HPV) Vaccine Schedules in 9-14 Year Old Girls

This study has been designed to evaluate the immunogenicity and safety of GSK Biologicals' HPV-16/18 vaccine when administered according to alternative 2-dose schedules (0,6 months and 0,1...

Training Study to Characterize Biomarkers to Chickenpox and Yellow Fever Vaccines

It is thought that vaccines trigger innate inflammatory responses to induce antigenspecific adaptive immunity (the desired effect), but excessive inflammation may lead to serious inflammat...

PANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced Cancer

Background: - Many cancers produce two proteins, carcinoembryonic antigen (CEA) and mucin-1 (MUC-1). - The PANVAC-V priming vaccine and PANVAC-F boosting vaccine contain human gene...

A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Candidate Vaccine (GSK2321138A) Manufactured Using a New Process in Adults and Children

The purpose of this trial is to demonstrate the acceptable safety profile and the immunological non-inferiority of the FLU D-QIV vaccine manufactured with this investigational process (FLU...

Trial of the Safety and Immunogenicity of an Oral, Replicating Ad26 Vectored HIV-1 Vaccine

This is a dose escalation study to test the safety and immunogenicity of an oral HIV-1 vaccine.

Maternal Tdap Immunization in Guatemala

Maternal immunization with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) is a potential strategy to protect young infants against pertussis before they ...

Pilot Trial of a WT-1 Analog Peptide Vaccine in Patients With Myeloid Neoplasms

The purpose of this study is to determine whether the WT-1 vaccine causes an immune response and is safe. The WT-1 vaccine is made up of protein pieces that the patient's immune system can...

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age

The purpose of this study is to support licensure of GSK Biologicals' MMR vaccine (Priorix®) in the US by generating immunogenicity and safety data in contrast to the US standard of care,...

Comparison of Dendritic Cells Versus Montanide as Adjuvants in a Melanoma Vaccine

In this study, a melanoma vaccine (5 melanoma peptides) is given with either Montanide or dendritic cells as adjuvants. This randomized trial will establish the safety of both vaccines and...

Medical and Biotech [MESH] Definitions

A combined vaccine used to prevent infection with diphtheria and tetanus toxoid. This is used in place of DTP vaccine (DIPHTHERIA-TETANUS-PERTUSSIS VACCINE) when PERTUSSIS VACCINE is contraindicated.

A live vaccine containing attenuated poliovirus, types I, II, and III, grown in monkey kidney cell tissue culture, used for routine immunization of children against polio. This vaccine induces long-lasting intestinal and humoral immunity. Killed vaccine induces only humoral immunity. Oral poliovirus vaccine should not be administered to immunocompromised individuals or their household contacts. (Dorland, 28th ed)

A bacterial vaccine for the prevention of brucellosis in man and animal. Brucella abortus vaccine is used for the immunization of cattle, sheep, and goats.

A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had mumps or been immunized with live mumps vaccine. Children are usually immunized with measles-mumps-rubella combination vaccine.

Vaccines used to prevent TYPHOID FEVER and/or PARATYPHOID FEVER which are caused by various species of SALMONELLA. Attenuated, subunit, and inactivated forms of the vaccines exist.

Search BioPortfolio:
Loading
Advertisement
Advertisement
review and buy Typhoid Vaccine Wyeth market research data and corporate reports here

Channels Quicklinks